Mitochondria are key structures providing most of the energy needed to maintain
homeostasis. They are the main source of adenosine triphosphate (ATP), participate in …

Multiple sclerosis (MS) is an inflammatory, chronic, demyelinating, and neurodegenerative
disorder of central nervous system, determined by an auto-immune dysfunction. Severe …

We aimed to assess dynamic changes in hemodynamic and autonomic function in response
to the head-up tilt test (HUTT) in patients with multiple sclerosis (MS) compared to healthy …

Polypharmacy (intake of≥ 5 drugs) is an important issue for patients with chronic diseases
such as multiple sclerosis (MS). We aimed to assess the prevalence of polypharmacy with …

Background Trait and state physical fatigue (trait-PF and state-PF) negatively impact many
people with multiple sclerosis (pwMS) but are challenging symptoms to measure. In this …

Background: Despite advancements in treatments of multiple sclerosis (MS), there is a lack
of awareness of early MS symptoms, especially in students and the public, contributing to …

Fatigue is a common symptom in Multiple Sclerosis (MS), and its assessment depends
entirely on patient reports. Importantly, managing MS symptoms is increasingly supported by …

Multiple sclerosis (MS) is a neurological disease that causes inflammation and
demyelination of the central nervous system. It progresses with episodic attacks and is …

Sažetak Multipla skleroza (MS) je kronična, autoimuna, demijelinizacijska bolest središnjeg
živčanog sustava (SŽS). Pojava umora u oboljelih od MS-a vrlo je čest klinički entitet s …

Up to 80% of people with MS experience Uhthoff's phenomenon, whereby heat exposure
drives a transient worsening of existing MS symptoms and physical disability. MS advocacy …